A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients

BACKGROUND: The benefit of adjuvant chemotherapy for IB/IIA non-small cell lung cancer (NSCLC) patients remains uncertain. This study aimed to develop a prognostic model to predict overall survival in resected NSCLC patients with T1-2N0-1M0 stage and identify optimal candidates for postoperative che...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Zhou, Juying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501081/
https://www.ncbi.nlm.nih.gov/pubmed/37703536
http://dx.doi.org/10.1177/10732748231197973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501081/
https://www.ncbi.nlm.nih.gov/pubmed/37703536
http://dx.doi.org/10.1177/10732748231197973

Ejemplares similares